Localized delivery of growth factors for angiogenesis and bone formation in tissue engineering

被引:106
作者
Bai, Yan [1 ]
Yin, Guangfu [1 ]
Huang, Zhongbing [1 ]
Liao, Xiaoming [1 ]
Chen, Xianchun [1 ]
Yao, Yadong [1 ]
Pu, Ximing [1 ]
机构
[1] Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China
基金
中国国家自然科学基金;
关键词
Angiogenesis; Bone formation; Growth factors; Localized delivery; FACTOR-I; ENDOTHELIAL-CELLS; MORPHOGENETIC PROTEIN-2; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; OSTEOGENIC DIFFERENTIATION; PROMOTING ANGIOGENESIS; SIGNAL-TRANSDUCTION; VESSEL FORMATION; FACTOR RELEASE;
D O I
10.1016/j.intimp.2013.04.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Angiogenesis is a key component of bone formation. Delivery of growth factors for both angiogenesis and osteogenesis is about to gain important potential as a future therapeutic tool. This review focuses on these growth factors that have dual functions in angiogenesis and osteogenesis, and their localized application. A major hurdle in the clinical development of growth factor therapy so far is how to assure safe and efficacious therapeutic use of such factors and avoid unwanted side effects and toxicity. It is now firmly established from the available information that the type, dose, combinations and delivery kinetics of growth factors all play a decisive role for the success of growth factor therapy. All of these parameters have to be adapted and optimized for each animal model or clinical case. In this review we discuss some important parameters associated with growth factor therapy and present an overview of selected preclinical studies, followed by a conceptual description of both established and proposed delivery strategies meeting therapeutic needs. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:214 / 223
页数:10
相关论文
共 181 条
[1]
ERYTHROPOIETIN HAS A MITOGENIC AND POSITIVE CHEMOTACTIC EFFECT ON ENDOTHELIAL-CELLS [J].
ANAGNOSTOU, A ;
LEE, ES ;
KESSIMIAN, N ;
LEVINSON, R ;
STEINER, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :5978-5982
[2]
Growth factor delivery for tissue engineering [J].
Babensee, JE ;
McIntire, LV ;
Mikos, AG .
PHARMACEUTICAL RESEARCH, 2000, 17 (05) :497-504
[3]
BMP-2, VEGF and bFGF synergistically promote the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells [J].
Bai, Yan ;
Li, Peipei ;
Yin, Guangfu ;
Huang, Zhongbing ;
Liao, Xiaoming ;
Chen, Xianchun ;
Yao, Yadong .
BIOTECHNOLOGY LETTERS, 2013, 35 (03) :301-308
[4]
Vascular endothelial growth factor can signal through platelet-derived growth factor receptors [J].
Ball, Stephen G. ;
Shuttleworth, C. Adrian ;
Kielty, Cay M. .
JOURNAL OF CELL BIOLOGY, 2007, 177 (03) :489-500
[5]
BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565
[6]
Combination of bone marrow and TGF-β1 augment the healing of critical-sized bone defects [J].
Beck, LS ;
Wong, RL ;
DeGuzman, L ;
Lee, WP ;
Ongpipattanakul, B ;
Nguyen, TH .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (11) :1379-1386
[7]
Transforming growth factor-β signal transduction in angiogenesis and vascular disorders [J].
Bertolino, P ;
Deckers, M ;
Lebrin, F ;
ten Dijke, P .
CHEST, 2005, 128 (06) :585S-590S
[8]
Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit [J].
Bland, YS ;
Critchlow, MA ;
Ashhurst, DE .
ACTA ORTHOPAEDICA SCANDINAVICA, 1995, 66 (06) :543-548
[9]
Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: Implications for fracture healing [J].
Bouletreau, PJ ;
Warren, SM ;
Spector, JA ;
Peled, ZM ;
Gerrets, RP ;
Greenwald, JA ;
Longaker, MT .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2002, 109 (07) :2384-2397
[10]
Depressed bone mineralization following high dose TGF-β1 application in an orthopedic implant model [J].
Broderick, E ;
Infanger, S ;
Turner, TM ;
Sumner, DR .
CALCIFIED TISSUE INTERNATIONAL, 2005, 76 (05) :379-384